ASPG and acute lymphoblastic leukemia: Complete response rates range between 91% and 98%, with an unprecedented 4-year overall survival rate of up to 71%.[1] The relapse rate of pediatric patients with Ph+ ALL is high when they receive an inadequate course of the planned asparaginase therapy.